Medizone International, Inc.(OTCBB: MZEI)

VIEW PROFILE – VIEW MEDIZONE WEB SITE

Dear Members:

Today represents a great opportunity for MZEI.  Yesterday’s news continues to confirm the amazing opportunities.  I have the utmost confidence in this company and believe the ELIMINATION OF SUPER BUGS in a world where Hospital Acquired Infections kill THREE TIMES AS MANY PEOPLE AS AIDs is a gigantic step forward.

Strange how share price does not immediately follow GREAT NEWS LIKE THIS: AsepticSure(TM) Eliminates All Pathogens

Medizone has come a long, long way since it was first introduced by Stock Guru on June 2, 2009, at $00.042.  (four cents).

MZEI has been completely successful in the completion of the first full round of room scale testing with AsepticSure™.

With the design of the first pre-manufacturing prototype about to begin we can see the commercialization of AsepticSure™ in the very near future.

If there were a solution on the market now 100,000 people a year would NOT be dying from Hospital Acquired Infections.  Medizone International has a very important solution.

Contact information:
Medizone International, Inc. (OTC: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone:  415-868-0300
Fax:  415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 532,200 144 restricted common shares by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We currently hold 332,200 shares.

Medizone International, Inc.(OTCBB: MZEI)

VIEW PROFILE – VIEW MEDIZONE WEB SITE

MZEI was introduced by Stock Guru on June 2, 2009, at $00.042.  (four cents).   MZEI is now it is the $0.25 range.

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure.   A  hospital unit is currently being readied for scale up testing.

Given the outstanding range of bactericidal kill rates achieved to date with the pathogens most often associated with hospital derived infections, it has become clear there are opportunities abounding to expand scientific horizons through collaborative arrangements in many diverse and exciting new applications.

Commercial Viability of AsepticSure™ Hospital Sterilization System

From a commercial viewpoint, the higher the “kill rate” in the shortest turn around time, the more favorably physicians and hospital administrators will view the system. Accordingly, Medizone now believes that the performance profile of its AsepticSure™ Sterilization System will exceed all the prerequisite requirements of affordability, practicability and unmatched efficacy, which will catapult it into the world market.

Contact information:
Medizone International, Inc. (OTC: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone:  415-868-0300
Fax:  415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 532,200 144 restricted common shares by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We currently hold 332,200 shares.

Medizone International, Inc.(OTCBB: MZEI)

VIEW PROFILE – VIEW MEDIZONE WEB SITE

MZEI was introduced by Stock Guru on June 2, 2009, at $00.042.  (four cents). 

MZEI is now it is the $0.25 range.

Medizone International has a product for which there is a phenomenal need.  

The AsepticSure™ sterilization system is effective against pathogens which cause Hospital Acquired Infections.

These statistics may be shocking but they are true and underscore the reason Medizone International has such a bright, bright future and should be a cornerstone of your portfolio.

Hospital-associated infections are not what bring you to the hospital, but what happens once you are there.

• Hospital Acquried Infections are one of the ten-leading causes of death in America.
• More people die from hospital-acquired infections than from homicides and car accidents combined.
• Hospital acquired infections kill three times more Americans than HIV does.

AsepticSure™  has reached the accepted sterilization standard of 6 logs or greater (99.9999% bactericidal kill.)  

Medizone is the only company in the world known to have reached this standard, and it has done so using a product that is portable, affordable and is now proving capable of full room sterilization with a turn around time of 2 hours or less for re-use, while not damaging electronics and other built in infrastructure within the room.

Contact information:
Medizone International, Inc. (OTC: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone:  415-868-0300
Fax:  415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 532,200 144 restricted common shares by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We currently hold 332,200 shares.

Medizone International, Inc. (OTCBB:  MZEI) IS CLOSE TO BEING ABLE TO MARKET A DESPERATELY NEEDED PRODUCT.

AsepticSure™ is anticipated to reach full commercialization in the area of hospital sterilization and critical infrastructure clean up in the very near future. 

This is in addition to the strong likelihood of working as a bio-terrorism counter measure.

These two very different and extremely broad scopes of potential revenue production have a huge potential for vast commercial success.

AsepticSure™  has reached the accepted sterilization standard of 6 logs or greater (99.9999% bactericidal kill.)  

Medizone is the only company in the world known to have reached this standard, and it has done so using a product that is portable, affordable and is now proving capable of full room sterilization with a turn around time of 2 hours or less for re-use, while not damaging electronics and other built in infrastructure within the room.

Full room scale testing achieved total eradication (>6 logs) with all bacteria tested to date (MRSA, VRE and E coli) on every single run.  

Medizone will in very short order becoe a revenue producing company.

Medizone International Has the Major Cornerstone for a Solution to Hospital Acquired Infection Super Bugs.

Here is a real chance to be in a company shortly before it delivers a solution to a serious national and international problem.

Contact information:
Medizone International, Inc. (OTC: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone:  415-868-0300
Fax:  415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Medizone International, Inc. (OTC:  MZEI)

Hospital Acquired Infections -  are beginning to rank with the disclosure and healthy histories in this country of mercury, asbestos and tobacco.  You know the story: deny, lie and cover-up until you just cannot no longer keep it quiet.  This week we witnessed every major news organization in this country carry the results of a Think Tank investigation into Hospital Acquired Infections.  This cause is becoming main stream.

Medizone is delivering an important solution to Hospital Acquired Infections.

We saw in the news just this week yet ANOTHER study which addressed the expanding awareness of a the growing and underlying problem of Hospital Acquired Infections.   You know the ones where you go into the hospital relatively healthy and come out DEAD six weeks later.

Resources for the Future, a D.C. Think Tank published a study addressing Hospital Acquired Infections.  The senior researcher noted, “When a patient goes to the hospital for another illness and dies of pneumonia, it does not always occur to the family that it was a mistake. But if that same patient went to the hospital and got blood tainted with HIV, the response would be quite different.”

The Think Tank’s press release put this issue in perspective:

Hospital acquired infections actually kill three times more Americans than HIV does. Yet we’re only beginning to get a handle on the size of the problem. That’s because it’s been very hard to separate out the costs — in terms of lives, suffering, and money — from the suffering caused by the illnesses and injuries that land people in the hospital in the first place.

Laxminarayan and colleagues analyzed administrative data from a huge national database of information on hospital records for 69 million U.S. residents in 40 states between 1998 and 2006. They focused only on infections acquired in the hospital, and not on infections picked up in the community.

Most of the infections come from using catheters and ventilators. Some of the germs causing the infections have been around for years; others are scary new bugs such as the MRSA staph “superbug.”

We have seen this before with asbestos, mercury and tobacco.  Eventually, governments and the media take the issue and deal with it.  This country is in the midst of that reality, NOW.

Medizone has announced that every full scale test run completed thus far in its hospital room mock up facility has resulted in the total elimination of all bacteria present in the room. In this current phase of development, Medizone’s scientific team will attempt to confirm, in a more realistic hospital setting, recent laboratory findings indicating extremely high antibacterial efficacy for its novel technology (6-7.2 log reductions) against the primary causative agents of hospital acquired infections (HAIs), sometimes referred to as “Super Bugs”.

Here is a real chance to be in a company shortly before it delivers a solution to a serious national and international problem.

Contact information:
Medizone International, Inc. (OTC: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone:  415-868-0300
Fax:  415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Medizone International, Inc. (OTCBB: MZEI) From a commercial viewpoint, the higher the “kill rate” in the shortest turn around time, the more favorably physicians and hospital administrators will view the system. Accordingly, Medizone now believes that the performance profile of its AsepticSure™ Sterilization System will exceed all the prerequisite requirements of affordability, practicability and unmatched efficacy, which will catapult it into the world market.

What we are witnessing here is not only AsepticSure  moving beyond expectations in its hospital setting but broading the product scope and potential sales into bioterrorism applications.

AsepticSure™ BioTerrorism Applications

A field hardened version of AsepticSure™ is anticipated to be used in bioterrorism settings internationally as it will be easily deployable in response to virtually any terrorist assault, extremely effective against a broad range of lethal pathogens, easy to manage and maintain and has the potential to save lives. The potential of being able to eliminate 99.999992% (7.2 log kill) of an internationally accepted surrogate for Anthrax in 90 minutes will have national security implications.

This is precisely the time in the life of a biotech that you want to be on boaord.

January 20. 2010, Update

Unprecedented Kill Rates Foundation for Second Patent Application and Full Scale Hospital Mockup Underway

Medizone International announced unprecedented success in being able to predictably achieve 6 log (99.9999%) kill rates for the causative agents of Hospital Acquired Infections (HAIs) represented with AsepticSure™.

All samples tested during the third round of trials were either completely destroyed, that is no growth compared to the control samples, or so significantly reduced that the effect met the 6 log definition for sterilization.

These are the biggest culprits in hospital deaths for hospital acquired infections.  MZEI is hitting the bullseye here. NO DOUBT ABOUT IT.

This is HUGE.

The actual results of this series of tests indicate reductions in pathogens, commonly associated with HAIs, can reliably be achieved by AsepticSure™ as follows:

• >6.5 log for C difficile
• >7 log for MRSA
• 7 log for E-coli
• 6.6 log for VRE
• 7 log for Pseudomonas aeruginous
• > 7 log for Bacillus subtilis

The sterilization of contaminated hospital spaces with a fully portable unit is now within reach without enormous expense, which will translate into greatly reduced suffering, thousands of lives saved and a dramatic cost benefit for the health care system globally.

Full Scale Hospital Mock Up Underway

Medizone’s research has now progressed to the full-scale mock up. By introducing the same combinations and protocols to room scale testing that produced >6 log with all HAI pathogens in the laboratory, our research team is confident the results produced should coincide with what has already been achieved in the most recent round of laboratory trials. Initial results from these scale-up trials can be expected in the near future.

DO NOT WAIT ON THIS.  ONCE THE HOSPITAL MOCK UP RESULTS ARE ANNOUNCED THIS TRAIN MAY HAVE LEFT THE STATION.

YOU MAY NEVER FIND A BETTER TIME THAN NOW TO ABSOLUTELY GET ON BOARD.

Contact information:
Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.